Gilead Sciences News

The Planning Commission will consider a proposed major expansion of Gilead Sciences' corporate campus at a meeting tonight and make a series of recommendations to the City Council.

Dow Jones Reprints: This copy is for your personal, non-commerical use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool on any article or visit www.djreprints.com PRACTICALLY IGNORED BY INVESTORS THIS YEAR, drug maker Gilead Sciences deserves more support for its leading ...

Huge numbers of nonprofits exist that are devoted to caring, educating and treating patients diagnosed with HIV and other life threatening diseases.

Gilead Sciences, Inc. cordially invites you to attend the Beyond the Diagnosis community based theater performance in Harlem, NY.

China will provide two imported HIV drugs to patients who develop resistance to cheaper, domestic alternatives, state media said on Monday, going some way to meeting a key demand of AIDS treatment activists.

Pearl Therapeutics Inc., a biopharmaceutical company developing therapeutic products for the treatment of chronic respiratory diseases, today announced the appointment of Howie Rosen to the company's Board of Directors.

MADISON, Wis.-- --BioSystem Development, LLC., a privately held life science analytics company, announces a recently completed investment round that raised just over 1.4 million dollars... LISLE, Illinois-- --SmartSignal Corporation ha annunciato oggi che Gas Natural ha selezionato il software SmartSignal EPI*Center per il monitoraggio di 22 ...

Britain's Health Protection Agency said five cases have been confirmed in Wales of patients infected with H1N1 resistant to oseltamivir -- the generic name of Roche and Gilead Sciences Inc 's antiviral drug Tamiflu.

Gilead Sciences, Inc. and GlaxoSmithKline today announced a licensing agreement to commercialize Viread for the treatment of chronic hepatitis B infection in adults in five countries in Asia.

The purpose of this article is to encourage the American people to read information on drugs they are being prescribed -- especially prescribed to their children -- and to read, read, read ingredients contained on labels -- especially what is being ingested by children.

While the market has staged a nice comeback since the spring and the economy seems to be slowly righting itself, things are still rough out there.

Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks.

H&Q Healthcare Investors appears to a be a decent value now within the closed-end fund universe.

Over his 28 years, Burrill's clients have included Steve Jobs of Apple, Genentech, Amgen and Gilead Sciences.

Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, biotech giant Gilead Sciences has earned a coveted five-star ranking .

David Gardner called it. Hea TMs up 1,334%! See what Davida TMs recommending that you buy NEXT.

Filed under: Market matters , Abbott Laboratories , Aetna Inc , CIGNA Corp , Gilead Sciences , Stocks to Buy , Cramer on BloggingStocks TheStreet.com's Jim Cramer says the Senate is filled with more-savvy politicians, and the upside for beaten-down names is huge.

FreeBalance , a leading global provider of software solutions for public financial management, is pleased to announce the results of its most recent internal audit which show a dramatic increase in the size and scope of FreeBalance Government Resource Planning software implementations worldwide since 2006.

GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/04/09, Genta Incorporated announced the Company will release its third quarter 2009 financial results on Monday, November 16, 2009.